aHealth Management and Promotion Center, Hiroshima Atomic Bomb Casualty Council,

bDepartment of Regenerative Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University

cDepartment of General Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences

dDepartment of Biostatistics, Medical Center for Translational and Clinical Research, Hiroshima University Hospital

eDepartment of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan

Correspondence to Nobuo Sasaki, MD, Health Management and Promotion Center, Hiroshima Atomic Bomb Casualty Council, 3-8-6, Senda-machi, Naka-ku, Hiroshima 730-0052, Japan. Tel: +81 82 243 2451; fax: +81 82 504 4851; e-mail: [email protected]

Abbreviations: CI, confidence interval; CVD, cardiovascular disease; FPG, fasting plasma glucose; GMCVD, Glucose Metabolism and Cardiovascular Diseases; NFG, normal fasting glucose; NGT, normal glucose tolerance; OGTT, oral glucose tolerance test

Received 1 March, 2023

Revised 4 August, 2023

Accepted 12 January, 2024

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.jhypertension.com).